Investment Analysts' Updated EPS Estimates for February 13th (ALT, EDAP, ENVA, FLEX, HEES, HLIT, LZB, MLP, PPL, PRI)
Investment Analysts’ updated eps estimates for Tuesday, February 13th: Altimmune (NASDAQ:ALT) had its buy rating reiterated by analysts at B. Riley. They currently have a $20.00 target price on the stock. Edap Tms (NASDAQ:EDAP) was downgraded by analysts at StockNews.com from a hold rating to a sell rating. Enova International (NYSE:ENVA) was downgraded by analysts […]
Source: modernreaders.com